Neumora Therapeutics, Inc. (NMRA): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$117.0K
Year ended 2023-12-31
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $117.0K | -77.1% | 2025-03-03, From 2023-01-01 |
| 2022-12-31 | $511.0K | n/a | 2025-03-03, From 2022-01-01 |